Spots Global Cancer Trial Database for Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls
Official Title: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 Vaccine When Administered According to Alternative 2-dose Schedules in 9 - 14 Year Old Females
Study ID: NCT01381575
Conditions
Interventions
Study Description
Brief Summary: This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,12 months) in healthy 9-14 year old females as compared to the standard 3-dose schedule (0,1,6 months) in 15-25 year old females.
Detailed Description:
Eligibility
Minimum Age: 9 Years
Eligible Ages: CHILD, ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
GSK Investigational Site, Coquitlam, British Columbia, Canada
GSK Investigational Site, Halifax, Nova Scotia, Canada
GSK Investigational Site, Sudbury, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Woodstock, Ontario, Canada
GSK Investigational Site, Sherbrooke, Quebec, Canada
GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Kehl, Baden-Wuerttemberg, Germany
GSK Investigational Site, Schoenau Am Koenigssee, Bayern, Germany
GSK Investigational Site, Wuerzburg, Bayern, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Wolfenbuettel, Niedersachsen, Germany
GSK Investigational Site, Wolfsburg, Niedersachsen, Germany
GSK Investigational Site, Kleve-Materborn, Nordrhein-Westfalen, Germany
GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany
GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany
GSK Investigational Site, Trier, Rheinland-Pfalz, Germany
GSK Investigational Site, Flensburg, Schleswig-Holstein, Germany
GSK Investigational Site, Weimar, Thueringen, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Genova, Liguria, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Cuneo, Piemonte, Italy
GSK Investigational Site, Cagliari, Sardegna, Italy
GSK Investigational Site, Ragusa, Sicilia, Italy
GSK Investigational Site, Padova, Veneto, Italy
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Taoyuan, , Taiwan
GSK Investigational Site, Bangkok, , Thailand
GSK Investigational Site, Chiangmai, , Thailand
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
